In this study, a significant contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade was convincingly demonstrated in transplantable, spontaneous or genetically induced mouse tumour models [62]. The gene discussed is PDCD1; the disease is neoplasm.